These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1970496)

  • 1. No evidence for differences between pre- and postjunctional alpha 2-adrenoceptors in the periphery.
    Connaughton S; Docherty JR
    Br J Pharmacol; 1990 Jan; 99(1):97-102. PubMed ID: 1970496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors.
    Oriowo MA; Hieble JP; Ruffolo RR
    Pharmacology; 1991; 43(1):1-13. PubMed ID: 1683709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional evidence for heterogeneity of peripheral prejunctional alpha 2-adrenoceptors.
    Connaughton S; Docherty JR
    Br J Pharmacol; 1990 Oct; 101(2):285-90. PubMed ID: 1979507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
    Akers I; Coates J; Drew GM; Sullivan AT
    Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that SK & F 104078 does not differentiate between pre- and postjunctional alpha 2-adrenoceptors.
    Connaughton S; Docherty JR
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):379-82. PubMed ID: 2907608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856.
    Hieble JP; Sulpizio AC; Edwards R; Chapman H; Young P; Roberts SP; Blackburn TP; Wood MD; Shah DH; Demarinis RM
    J Pharmacol Exp Ther; 1991 Nov; 259(2):643-52. PubMed ID: 1682482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic differentiation between pre- and postjunctional alpha 2-adrenoceptors by SK&F 104078.
    Ruffolo RR; Sulpizio AC; Nichols AJ; DeMarinis RM; Hieble JP
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):415-8. PubMed ID: 2893296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations of prejunctional alpha 2-adrenoceptors in rat atrium, vas deferens and submandibular gland.
    Smith K; Connaughton S; Docherty JR
    Eur J Pharmacol; 1992 Feb; 211(2):251-6. PubMed ID: 1351849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for heterogeneity between pre- and postjunctional alpha-2 adrenoceptors using 9-substituted 3-benzazepines.
    Daly RN; Sulpizio AC; Levitt B; DeMarinis RM; Regan JW; Ruffolo RR; Hieble JP
    J Pharmacol Exp Ther; 1988 Oct; 247(1):122-8. PubMed ID: 2902209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the neuronal ATP release from guinea-pig vas deferens subject to alpha 2-adrenoceptor-mediated modulation?
    Sperlágh B; Vizi ES
    Neuroscience; 1992 Nov; 51(1):203-9. PubMed ID: 1361216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the prejunctional alpha 2-adrenoceptors of the rat vas deferens and submandibular gland of the alpha 2A- or alpha 2D-subtype?
    Smith K; Docherty JR
    Eur J Pharmacol; 1992 Aug; 219(2):203-10. PubMed ID: 1358640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
    Doxey JC; Roach AG; Smith CF
    Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of potency of alpha 2-adrenoceptor antagonists in vitro: evidence for heterogeneity of alpha 2-adrenoceptors.
    Alabaster VA; Keir RF; Peters CJ
    Br J Pharmacol; 1986 Jul; 88(3):607-14. PubMed ID: 2874857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prejunctional alpha 1-adrenoceptors modify release of [3H]noradrenaline in the guinea-pig vas deferens.
    Ellis JL; Kasakov L; Vlaskovska M; Burnstock G
    Gen Pharmacol; 1990; 21(1):53-7. PubMed ID: 2153609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for neuro-effector transmission through postjunctional alpha 2-adrenoceptors in human saphenous vein.
    Docherty JR; Hyland L
    Br J Pharmacol; 1985 Feb; 84(2):573-6. PubMed ID: 2983815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.
    Hieble JP; Sulpizio AC; Nichols AJ; Willette RN; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Nov; 247(2):645-52. PubMed ID: 2903236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alpha (1D)-adrenoceptor antagonist BMY 7378 is also an alpha (2C)-adrenoceptor antagonist.
    Cleary L; Murad K; Bexis S; Docherty JR
    Auton Autacoid Pharmacol; 2005 Oct; 25(4):135-41. PubMed ID: 16176444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An attempt at selective protection from phenoxybenzamine of postjunctional alpha-adrenoceptor subtypes mediating contractions to noradrenaline in the rabbit isolated saphenous vein.
    Daly CJ; Dunn WR; McGrath JC; Wilson VG
    Br J Pharmacol; 1988 Oct; 95(2):501-11. PubMed ID: 2906558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of age-related changes in pre- and postjunctional alpha-adrenoceptors in human saphenous vein.
    Hyland L; Docherty JR
    Eur J Pharmacol; 1985 Aug; 114(3):361-4. PubMed ID: 2998813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC; Roach AG; Strachan DA; Virdee NK
    Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.